Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tap

Showing results (101-110 of 235) with videos related to

Pageof 24
Sort By:
Cancer Discovery|December 12, 2012
Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatmentDaniel Braas, Ethan Ahler, Brenna Tam, et al.
NPJ Precision Oncology|May 7, 2025
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomasCarla Saoud, Josephine K Dermawan, Kanika Arora, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2021
Exposure-response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumorOphelia Yin, Hamim Zahir, Jonathan French, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapyKen Herrmann, Matthias R Benz, Johannes Czernin, et al.
The Lancet. Oncology|January 27, 2018
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trialsSandra P D'Angelo, Michelle R Mahoney, Brian A Van Tine, et al.
Human Pathology|December 27, 2014
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironmentSandra P D'Angelo, Alexander N Shoushtari, Narasimhan P Agaram, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2022
Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlatesJosephine K Dermawan, Fabio Vanoli, Laurie Herviou, et al.
Oncogene|May 24, 2018
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescenceMary E Klein, Mark A Dickson, Cristina Antonescu, et al.
The Annals of Thoracic Surgery|October 28, 2017
Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?Neel P Chudgar, Murray F Brennan, Kay See Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumorsWilliam D Tap, George Demetri, Phillip Barnette, et al.
Pageof 24

Showing results (101-110 of 235) with videos related to

Sort By:
Pageof 24
Cancer Discovery|December 12, 2012
Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatmentDaniel Braas, Ethan Ahler, Brenna Tam, et al.
NPJ Precision Oncology|May 7, 2025
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomasCarla Saoud, Josephine K Dermawan, Kanika Arora, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2021
Exposure-response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumorOphelia Yin, Hamim Zahir, Jonathan French, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapyKen Herrmann, Matthias R Benz, Johannes Czernin, et al.
The Lancet. Oncology|January 27, 2018
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trialsSandra P D'Angelo, Michelle R Mahoney, Brian A Van Tine, et al.
Human Pathology|December 27, 2014
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironmentSandra P D'Angelo, Alexander N Shoushtari, Narasimhan P Agaram, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2022
Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlatesJosephine K Dermawan, Fabio Vanoli, Laurie Herviou, et al.
Oncogene|May 24, 2018
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescenceMary E Klein, Mark A Dickson, Cristina Antonescu, et al.
The Annals of Thoracic Surgery|October 28, 2017
Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?Neel P Chudgar, Murray F Brennan, Kay See Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumorsWilliam D Tap, George Demetri, Phillip Barnette, et al.
Pageof 24